About Us

About Us

Company Profile

Company Profile

Sino Biopharm, together with its subsidiaries, is a leading, innovative research and development driven pharmaceutical conglomerate in China, with a business scope that is vertically integrated including research and development, manufacturing and sales and marketing infrastructure. Its product offerings include a variety of biological drugs and chemical drugs, and in the therapeutics areas including as hepatology, oncology, cardiovascular and cerebrovascular diseases, orthopedics, digestive, immune and respiratory diseases.

What are we going to do

Our Vision
Our Vision
To be a leading global pharmaceutical company through delivering innovative therapies for patients.
Our Mission
Our Mission
Improving the quality and protecting the dignity of human life.
Our Values
Our Values
Integrity, Foresight, Innovation, Commitment, Efficiency,
Collaboration
Our Principle
Our Principle
Our business should benefit not just our company and our employees but also the communities and patients we serve and the countries we operate in.

How to realize

  • For the Country

    Leading the Innovation and Development of Chinese Pharmaceutical Technology
    Become the quality benchmark of the industry
    Create 20,000 jobs for the country
    The cumulative tax payment between 2015 and 2017 exceeded 11 billion RMB
    China's Largest Prescription Pharmaceutical Company
    We strive to bring better new drugs to our country.
  • For the People

    Improving the quality of life
    Maintaining the Dignity of Life
    Let the people use high-quality and inexpensive medicines
    Cooperation with more than 6000 domestic hospitals
    Provide patients with a variety of quality and effective treatment options
  • For the Company(Shareholders, employees)

    Create extraordinary value for enterprises
    Contribute generous returns to shareholders
    The company's market value has increased 472 times since its listing 17 years ago
    Bring more than $4 billion in cash dividends to shareholders